Catherine E Handy1, Chintan S Desai1, Zeina A Dardari1, Mouaz H Al-Mallah2, Michael D Miedema3, Pamela Ouyang1, Matthew J Budoff4, Roger S Blumenthal1, Khurram Nasir1,5,6,7, Michael J Blaha1. 1. The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland, USA. 2. Heart and Vascular Institute, Henry Ford Hospital, Detroit, MI, USA. 3. Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA. 4. Division of Cardiology, Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA, USA. 5. Center for Prevention and Wellness Research, Baptist Health Medical Group, Miami Beach, FL, USA. 6. Department of Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA. 7. Department of Epidemiology, Robert Stempel College of Public Health, Florida International University, Miami, FL, USA.
Abstract
OBJECTIVES: This study sought to determine if coronary artery calcium (CAC) is associated with incident noncardiovascular disease. BACKGROUND: CAC is considered a measure of vascular aging, associated with increased risk of cardiovascular and all-cause mortality. The relationship with noncardiovascular disease is not well defined. METHODS: A total of 6,814 participants from 6 MESA (Multi-Ethnic Study of Atherosclerosis) field centers were followed for a median of 10.2 years. Modified Cox proportional hazards ratios accounting for the competing risk of fatal coronary heart disease were calculated for new diagnoses of cancer, pneumonia, chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), deep vein thrombosis/pulmonary embolism, hip fracture, and dementia. Analyses were adjusted for age; sex; race; socioeconomic status; health insurance status; body mass index; physical activity; diet; tobacco use; number of medications used; systolic and diastolic blood pressure; total and high-density lipoprotein cholesterol; antihypertensive, aspirin, and cholesterol medication; and diabetes. The outcome was first incident noncardiovascular disease diagnosis. RESULTS: Compared with those with CAC = 0, those with CAC >400 had an increased hazard of cancer (hazard ratio [HR]: 1.53; 95% confidence interval [CI]: 1.18 to 1.99), CKD (HR: 1.70; 95% CI: 1.21 to 2.39), pneumonia (HR: 1.97; 95% CI: 1.37 to 2.82), COPD (HR: 2.71; 95% CI: 1.60 to 4.57), and hip fracture (HR: 4.29; 95% CI: 1.47 to 12.50). CAC >400 was not associated with dementia or deep vein thrombosis/pulmonary embolism. Those with CAC = 0 had decreased risk of cancer (HR: 0.76; 95% CI: 0.63 to 0.92), CKD (HR: 0.77; 95% CI: 0.60 to 0.98), COPD (HR: 0.61; 95% CI: 0.40 to 0.91), and hip fracture (HR: 0.31; 95% CI: 0.14 to 0.70) compared to those with CAC >0. CAC = 0 was not associated with less pneumonia, dementia, or deep vein thrombosis/pulmonary embolism. The results were attenuated, but remained significant, after removing participants developing interim nonfatal coronary heart disease. CONCLUSIONS: Participants with elevated CAC were at increased risk of cancer, CKD, COPD, and hip fractures. Those with CAC = 0 are less likely to develop common age-related comorbid conditions, and represent a unique population of "healthy agers."
OBJECTIVES: This study sought to determine if coronary artery calcium (CAC) is associated with incident noncardiovascular disease. BACKGROUND: CAC is considered a measure of vascular aging, associated with increased risk of cardiovascular and all-cause mortality. The relationship with noncardiovascular disease is not well defined. METHODS: A total of 6,814 participants from 6 MESA (Multi-Ethnic Study of Atherosclerosis) field centers were followed for a median of 10.2 years. Modified Cox proportional hazards ratios accounting for the competing risk of fatal coronary heart disease were calculated for new diagnoses of cancer, pneumonia, chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), deep vein thrombosis/pulmonary embolism, hip fracture, and dementia. Analyses were adjusted for age; sex; race; socioeconomic status; health insurance status; body mass index; physical activity; diet; tobacco use; number of medications used; systolic and diastolic blood pressure; total and high-density lipoproteincholesterol; antihypertensive, aspirin, and cholesterol medication; and diabetes. The outcome was first incident noncardiovascular disease diagnosis. RESULTS: Compared with those with CAC = 0, those with CAC >400 had an increased hazard of cancer (hazard ratio [HR]: 1.53; 95% confidence interval [CI]: 1.18 to 1.99), CKD (HR: 1.70; 95% CI: 1.21 to 2.39), pneumonia (HR: 1.97; 95% CI: 1.37 to 2.82), COPD (HR: 2.71; 95% CI: 1.60 to 4.57), and hip fracture (HR: 4.29; 95% CI: 1.47 to 12.50). CAC >400 was not associated with dementia or deep vein thrombosis/pulmonary embolism. Those with CAC = 0 had decreased risk of cancer (HR: 0.76; 95% CI: 0.63 to 0.92), CKD (HR: 0.77; 95% CI: 0.60 to 0.98), COPD (HR: 0.61; 95% CI: 0.40 to 0.91), and hip fracture (HR: 0.31; 95% CI: 0.14 to 0.70) compared to those with CAC >0. CAC = 0 was not associated with less pneumonia, dementia, or deep vein thrombosis/pulmonary embolism. The results were attenuated, but remained significant, after removing participants developing interim nonfatal coronary heart disease. CONCLUSIONS:Participants with elevated CAC were at increased risk of cancer, CKD, COPD, and hip fractures. Those with CAC = 0 are less likely to develop common age-related comorbid conditions, and represent a unique population of "healthy agers."
Authors: Ludmila N Bakhireva; Elizabeth L Barrett-Connor; Gail A Laughlin; Donna Kritz-Silverstein Journal: Menopause Date: 2005-11-08 Impact factor: 2.953
Authors: Leslee J Shaw; Ashley E Giambrone; Michael J Blaha; Joseph T Knapper; Daniel S Berman; Naveen Bellam; Arshed Quyyumi; Matthew J Budoff; Tracy Q Callister; James K Min Journal: Ann Intern Med Date: 2015-07-07 Impact factor: 25.391
Authors: Michael J LaMonte; Shannon J FitzGerald; Timothy S Church; Carolyn E Barlow; Nina B Radford; Benjamin D Levine; John J Pippin; Larry W Gibbons; Steven N Blair; Milton Z Nichaman Journal: Am J Epidemiol Date: 2005-08-02 Impact factor: 4.897
Authors: Chintan S Desai; Hongyan Ning; Joseph Kang; Aaron R Folsom; Joseph F Polak; Christopher T Sibley; Russell Tracy; Donald M Lloyd-Jones Journal: Am J Cardiol Date: 2013-03-15 Impact factor: 2.778
Authors: Rajesh Tota-Maharaj; Michael J Blaha; Ron Blankstein; Michael G Silverman; John Eng; Leslee J Shaw; Roger S Blumenthal; Matthew J Budoff; Khurram Nasir Journal: Mayo Clin Proc Date: 2014-09-15 Impact factor: 7.616
Authors: Isac C Thomas; Caroline A Thompson; Mingan Yang; Matthew A Allison; Nketi I Forbang; Erin D Michos; Robyn L McClelland; Matthew J Budoff; Michael H Criqui Journal: Arterioscler Thromb Vasc Biol Date: 2018-08 Impact factor: 8.311
Authors: J P Beckman; J J Camp; B D Lahr; K R Bailey; A E Kearns; V D Garovic; M Jayachandran; V M Miller; D R Holmes Journal: Climacteric Date: 2017-11-30 Impact factor: 3.005
Authors: Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2017-01-25 Impact factor: 29.690
Authors: Michael J Blaha; Seamus P Whelton; Mahmoud Al Rifai; Zeina A Dardari; Leslee J Shaw; Mouaz H Al-Mallah; Kuni Matsushita; John A Rumberger; Daniel S Berman; Matthew J Budoff; Michael D Miedema; Khurram Nasir Journal: J Cardiovasc Comput Tomogr Date: 2016-11-11
Authors: Philip Greenland; Michael J Blaha; Matthew J Budoff; Raimund Erbel; Karol E Watson Journal: J Am Coll Cardiol Date: 2018-07-24 Impact factor: 24.094
Authors: Akira Fujiyoshi; David R Jacobs; Annette L Fitzpatrick; Alvaro Alonso; Daniel A Duprez; A Richey Sharrett; Teresa Seeman; Michael J Blaha; José A Luchsinger; Stephen R Rapp Journal: Circ Cardiovasc Imaging Date: 2017-05 Impact factor: 7.792
Authors: Michael J Blaha; Miguel Cainzos-Achirica; Zeina Dardari; Ron Blankstein; Leslee J Shaw; Alan Rozanski; John A Rumberger; Omar Dzaye; Erin D Michos; Daniel S Berman; Matthew J Budoff; Michael D Miedema; Roger S Blumenthal; Khurram Nasir Journal: Atherosclerosis Date: 2019-11-16 Impact factor: 5.162
Authors: Ravi V Shah; Ashish S Yeri; Venkatesh L Murthy; Joe M Massaro; Ralph D'Agostino; Jane E Freedman; Michelle T Long; Caroline S Fox; Saumya Das; Emelia J Benjamin; Ramachandran S Vasan; Christopher J O'Donnell; Udo Hoffmann Journal: JAMA Cardiol Date: 2017-11-01 Impact factor: 14.676